EP3156048A1 — Stable pharmaceutical composition of linagliptin in the form of immediate release tablets
Assigned to Galenicum Health SL · Expires 2017-04-19 · 9y expired
What this patent protects
The present invention relates to stable pharmaceutical compositions of linagliptin in the form of immediate release tablets, to a process for the manufacture of said stable pharmaceutical compositions and to uniform pharmaceutical batches of said tablets.
USPTO Abstract
The present invention relates to stable pharmaceutical compositions of linagliptin in the form of immediate release tablets, to a process for the manufacture of said stable pharmaceutical compositions and to uniform pharmaceutical batches of said tablets.
Drugs covered by this patent
- Tradjenta (LINAGLIPTIN) · Boehringer Ingelheim
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.